Answers are grounded in this paper and cite their sources.
Capsule summary: Nasal basal cells are characterized by a diseased phenotype in allergic rhinitis, and in vitro assays demonstrated that this is correlated with impaired barrier formation capacity, highlighting them as an interesting potential therapeutic target.
No takes yet. Share an insight, caveat, or question.
Ruysseveldt et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: